Sigvotatug vedotin | Interleukin Related interleukin-related.com

Product Name :
Sigvotatug vedotin

Search keywords :
Integrin beta 6

drugId :
null

Target Vo:
Integrin beta-6

Target Vo Short Name :
ITGB6

Moa_Name:
Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Seagen Inc

Active Company_Name :
Bsp Pharmaceuticals Spa

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GSK3 beta Rabbit mAb supplier
Tarextumab In Vivo
Cyclin B2 Antibody: Cyclin B2 Antibody is an unconjugated, approximately 45 kDa, anti-Cyclin B2 monoclonal antibody. Cyclin B2 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human, mouse, rat background without labeling.

Author: Interleukin Related

Related Posts